| Henkel Healthcare Center | |
|
381 Southwood Court Bowling Green KY 42101-7513 | |
| (279) 793-5390 | |
| (279) 493-5396 |
| Full Name | Henkel Healthcare Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 381 Southwood Court, Bowling Green, Kentucky |
| Authorized Official Name and Position | Jon Leizman (PRESIDENT) |
| Authorized Official Contact | 2164799063 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Henkel Healthcare Center 5500 Maryland Way Ste 120 Brentwood TN 37027-4993 Ph: () - | Henkel Healthcare Center 381 Southwood Court Bowling Green KY 42101-7513 Ph: (279) 793-5390 |
| NPI Number | 1144633892 |
|---|---|
| Provider Enumeration Date | 06/10/2014 |
| Last Update Date | 08/15/2022 |
| Medicare PECOS PAC ID | 9133341464 |
|---|---|
| Medicare Enrollment ID | O20141120001962 |
News Archive
Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus - in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.
A team of researchers, led by scientists at the University of California, San Diego, have identified a key player in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson's disease.
GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144633892 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
| Provider Name | Thomas Houston Vogler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194097105 PECOS PAC ID: 0840454427 Enrollment ID: I20120611000686 |
News Archive
Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus - in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.
A team of researchers, led by scientists at the University of California, San Diego, have identified a key player in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson's disease.
GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.
› Verified 8 days ago
| Provider Name | Lena M Gokey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942540018 PECOS PAC ID: 3375789738 Enrollment ID: I20130410000142 |
News Archive
Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus - in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.
A team of researchers, led by scientists at the University of California, San Diego, have identified a key player in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson's disease.
GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.
› Verified 8 days ago
| Provider Name | Robert L Tippens |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346552932 PECOS PAC ID: 9032331384 Enrollment ID: I20141120002454 |
News Archive
Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus - in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.
A team of researchers, led by scientists at the University of California, San Diego, have identified a key player in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson's disease.
GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.
› Verified 8 days ago
| Provider Name | Alanna M Fenlon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457690232 PECOS PAC ID: 9830406198 Enrollment ID: I20151229000478 |
News Archive
Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus - in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.
A team of researchers, led by scientists at the University of California, San Diego, have identified a key player in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson's disease.
GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.
› Verified 8 days ago
News Archive
Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus - in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.
A team of researchers, led by scientists at the University of California, San Diego, have identified a key player in the dramatic loss of neurons in mice and fly models, a discovery that could help illuminate the role of mitochondrial dysfunction in human neurodegenerative disorders, such as Parkinson's disease.
GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.
› Verified 8 days ago
Verdant Healthcare Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1300 Andrea St, Suite 100, Bowling Green, KY 42104 Phone: 270-780-3546 Fax: 270-780-3547 | |
Cumberland Family Medical Center, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2464 Cumberland Trace Road, Bowling Green, KY 42103 Phone: 844-435-0900 Fax: 270-858-4029 | |
Western Kentucky Orthopaedic And Neurosurgical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 165 Natchez Trace Ave, Suite 200, Bowling Green, KY 42103 Phone: 270-782-7800 Fax: 270-843-0779 | |
Cumberland Family Medical Center, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2650 Plano Road, Bowling Green, KY 42104 Phone: 844-435-0900 Fax: 270-858-4029 | |
Cumberland Family Medical Center, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2617 Russellville Road, Bowling Green, KY 42101 Phone: 844-435-0900 Fax: 270-858-4029 | |
Cumberland Family Medical Center, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1808 Loop Drive, Bowling Green, KY 42101 Phone: 844-435-0900 Fax: 270-858-4029 | |
Cumberland Family Medical Center, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 265 Lovers Lane, Bowling Green, KY 42103 Phone: 844-435-0900 Fax: 270-858-4029 |